Genes and post-term birth: late for delivery by unknown
Schierding et al. BMC Research Notes 2014, 7:720
http://www.biomedcentral.com/1756-0500/7/720CORRESPONDENCE Open AccessGenes and post-term birth: late for delivery
William Schierding1, Justin M O’Sullivan1,2, José G B Derraik1 and Wayne S Cutfield1,2*Abstract
Background: Recent evidence suggests that prolonged pregnancies beyond 42 weeks of gestation (post-term
births) are associated with long-term adverse health outcomes in the offspring.
Discussion: There is evidence that post-term birth has not only environmental causes, but also significant heritability,
suggesting genetic and/or epigenetic influences interact with environmental cues to affect gestational length.
Summary: As prolonged gestation is associated with adverse short- and long-term outcomes in the offspring,
further research into the underlying genetic and epigenetic causes of post-term birth could be of importance for
improving obstetric management.
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Preterm (<37 weeks of gestation) and post-term (≥42 weeks
of gestation) births can be described as the two ends of the
gestational age continuum. However, there is a disparity in
the amount of research allocated towards these ends of the
gestation spectrum. There is considerable research on the
short- and long-term effects of preterm birth, as well as into
its potential underlying causes [1]. In contrast, although
post-term birth is relatively common worldwide [2], it has
attracted far less attention [3]. However, recent evidence
suggests that prolonged pregnancies beyond 42 weeks are
associated with long-term adverse health outcomes in
the offspring [4,5]. Importantly, there is evidence that
while environmental stresses (e.g. malnutrition, insuffi-
cient myometrial contractility, intrauterine factors) play
a large role in birth timing, over 25% of the variation in
gestational age could be due to genetic effects [6]. More
specifically, post-term birth has a large heritability,
implicating genetics and/or epigenetics as contributing
factors on gestational age [7-10].* Correspondence: w.cutfield@auckland.ac.nz
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count as a term pregnancy?
Post-term pregnancies are defined as those extending to
or beyond 293 days (≥42 weeks) from the first day of the
last menstrual cycle (assuming a 28-day cycle) [11].
However, classification of post-term birth can be affected
by pregnancy complications and clinical uncertainty of
menstrual dating [3]. Further, there are pregnancies that
would become post-term without obstetric intervention,
such as induction at 41 weeks of gestation. Prior to active
management to prevent prolonged pregnancy, 19-20% of
pregnancies were post-term when women were allowed
to progress naturally to spontaneous labour [12]. ‘Best
practice’ guidelines recommend induction of labour at
41 weeks [13-15], but clinical management varies [16]
and approximately 2-5% of babies are born after 42
completed weeks of gestation [17]. Although induction
reduces acute risks [13], it does not alter the underlying
genetic influence on prolonged gestation and the associ-
ated risk profile. Therefore, we argue that the study of
post-term birth should include ‘post-term potential’, i.e.
those births that would have occurred post-term if left
unmanaged. The implementation of modern induction
practices has seen the post-term rate fall to under 5% of
total births. Therefore, based on Pekkanen et al.’s data
[12], as many as 15% of total term births could be classified
as ‘post-term potential’. As such, 25% of routine inductions
in low-risk pregnancies have prolonged pregnancy as the
primary cause for induction [18,19].tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
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Controversially, while epidemiological studies report a
higher incidence of stillbirths and neonatal deaths in
post-term pregnancies [3,20], the only randomized con-
trolled trial of intervention in prolonged pregnancy did
not observe this difference [21]. Despite the controversy,
post-term pregnancies are associated with many acute
risks, including utero-placental insufficiency, fetal distress,
non-progression, operative delivery (both operative vagi-
nal and Caesarean), macrosomia, shoulder dystocia, low
Apgar scores, and meconium aspiration [2,22,23]. Some
studies have reported increased rates of post-partum
haemorrhage following post-term delivery, especially in
first pregnancies [24,25], but others have not observed this
association [26]. These acute risks lead to increased
morbidity and mortality when compared to term
infants. Perinatal morbidity and mortality reach a nadir
in births at term (37–41 weeks), increasing as gestational
age deviates further from term, for both preterm and
post-term pregnancies [27].
Beyond the acute risks, there is limited but emerging
evidence that post-term birth can have long-term adverse
effects [4,5,28]. An adverse fetal environment, including
fetal growth restriction (which can occur with post-term
birth), has been associated with hypertension [29] and
obesity in adulthood [30]. Recent small studies have found
that post-term birth is associated with features of the
metabolic syndrome in mid-childhood and obesity in
mid-adolescence [4,5]. In a cross-sectional study, Ayyavoo
et al. found reduced insulin sensitivity, increased abdominal
fat, impaired night-time blood pressure profile, and higher
cholesterol levels in prepubertal children born post-term
[4] with ultrasound confirmation of gestation. In a Swedish
cohort followed longitudinally from birth to 16 years of age,
post-term boys were found to be at higher risk of increased
weight gain during childhood than term counterparts,
leading to a greater incidence of obesity in adolescence
[5]. As both of these are small studies, confirmation in
larger cohorts is needed. Future research is necessary to
better characterize the long-term health risks associated
with post-term birth, informing and potentially influen-
cing the obstetric management of prolonged pregnancies,
particularly around the induction of labour.
What epidemiological factors influence gestational age?
There are a number of maternal risk factors that have
been found to be associated with an increased risk of
post-term delivery. These include first-time birth,
maternal age over 30 years, obesity, poorer education,
lower socioeconomic status, ethnicity, and dietary
factors (e.g. high omega-3 or docosahexaenoic acid in-
take during the last half of pregnancy) [10,31-36]. The
intake of common medicines can also affect gestational
length, and low dose aspirin (a prostaglandin inhibitor)increases the likelihood of the pregnancy extending to
post-term [37,38].
What is the evidence of a genetic effect on length of
gestation?
Genetic factors explained 25-40% of the variation in
birth weight, fetal growth rate, and gestational age among
twins [6]. Chaudhari et al. discussed evidence of a genetic
predisposition for preterm birth including recurrence of
prematurity in mothers or across families, as well as an
increased incidence in certain ethnicities [39]. Similarly, a
history of post-term delivery in a previous pregnancy was
found to be the most important risk factor for post-term
births [40,41], which was observed across a range of
ethnicities [10]. Specifically, the risk of post-term delivery
increases from 7.7%, to 19.9%, and 30% if the preceding
birth was term, post-term, or extremely post-term
(>44 weeks), respectively [42]. Moreover, sister pairs
were more likely to experience post-term births than
comparable brother pairs and brother-sister pairs, suggest-
ing a possible transmission of genes down the mother-
daughter line [7].
However, paternal genetics cannot be discounted, as
the length of pregnancy differed by more than one week
in families where there were different fathers between
the index and subsequent birth [42]. This is further
supported by the observation that if either the mother
or father was born post-term, a child has an increased
risk of also being post-term (49% and 23% greater, respect-
ively), with further amplification of risk if both mother
and father were born post-term [43]. When comparing
maternal and fetal genetic influences on birth timing, fetal
(26%) and maternal (21%) genetic factors explained almost
half of the variation in gestational age, with environmental
factors explaining the rest [7]. In twins, the heritability of
post-term birth was estimated as 30%, with the association
being greater for monozygotic as opposed to dizygotic
twins, further implicating an underlying genetic (as op-
posed to environmental) influence [8].
To date there have been no studies examining the
effect of any specific common gene variant on prolonged
gestation. At the opposite end of the gestational age
spectrum, the major genetic determinants of preterm birth
(that could be used to diagnose or prevent prematurity)
also have yet to be found [44], as a meta-analysis of the
available studies has failed to support earlier associations of
preterm birth with genetic loci [9,45,46]. These studies have
included several single-nucleotide polymorphisms (SNPs)
located within the follicle stimulating hormone receptor
(FSHR) gene [47], a functional SNP in the promoter of the
Serpin Peptidase Inhibitor, Clade H (Heat Shock Protein
47), Member 1 (SERPINH1) gene [48], and the type 1
insulin-like growth factor receptor (IGF1R) gene [49].
However, it has been shown that inclusion of very preterm
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resulted in a decrease in the estimated genetic effect
on gestation, suggesting that the genetics of preterm,
term, and post-term births may differ [9]. Therefore,
while these studies indicate that the entire gestational
age spectrum is influenced by genetics, the specific
genes associated with preterm and post-term births could
be entirely different.
Beyond genetics: what are the effects of epigenetics on
gestational age?
Transmissible phenotypes may not result solely from
changes in the underlying DNA sequence. The epige-
nome can affect gene expression through DNA methyla-
tion, histone modification, chromatin folding, or small
inhibitory RNA. Thus, alterations in DNA organization
and packaging can enhance or suppress gene expression.
For example, acetylation, phosphorylation, or methylation
and ubiquitination of histone tails may alter the local
chromatin structure, modifying the accessibility of the
underlying DNA [50].
The epigenome is particularly susceptible to modifica-
tion during gestation, neonatal development, puberty, and
old age [51-54]. For instance, the relationship between
epigenetics, aberrant nutrition, and lifetime metabolic
dysfunction has been shown to have an effect in all of the
above time periods, as well as having a trans-generational
effect [55]. For post-term birth, the relevant time-period
likely extends from conception until the end of gestation
(i.e. the uterine environment), a period that is highly
susceptible to epigenetic alterations [56]. For example,
folate restriction in early gestation can cause global gen-
ome hypomethylation, restricting the ability of the fetus
to impose cell-specific epigenetic modification [57].
Epigenetic changes in the fetus during pregnancy may
affect length of gestation, with increased DNA methy-
lation at three regions - near the nuclear factor I/X
(CCAAT-binding transcription factor) (NFIX), Rap guan-
ine nucleotide exchange factor (GEF) 2 (RAPGEF2), and
methionine sulfoxide reductase B3 (MSRB3) genes - cor-
related with increased gestational age [58]. In addition,
one study has found an association between LINE-1 DNA
methylation (an inflammation marker) and preterm birth
[59]. However, to date, no studies have examined potential
epigenetic changes associated directly with post-term
birth.
Summary/future potential
Prolonged gestation is associated with adverse short-
and long-term outcomes in the offspring. Evidence for
the heritability of post-term birth suggests an important
connection between birth timing and underlying genetic
factors. This creates an important distinction where
the genes involved in ‘post-term potential’ could be anunderlying risk factor for later-in-life disease, despite
the ‘best practice’ to induce at 41 weeks. This raises
two possibilities: 1) the underlying genetic causes of
prolonged gestation (post-term potential) are directly
responsible for the adverse long-term health effects in
post-term individuals; or 2) prolonged gestation itself
leads to physiological alterations and associated epigenetic
changes, which in turn lead to long-term adverse effects.
Either way, a better understanding of the genetic and epi-
genetic factors leading to and/or resulting from post-term
birth could explain the mechanism leading to long-term
health risks. By understanding mechanisms underlying
causation (as opposed to just clinical symptoms or out-
comes), these risk prediction profiles could then form
guidelines for alternative obstetric management (discussed
for preterm birth in [60] and [61]). In the future, tests for
genetic risk of post-term birth could inform obstetric
treatment options earlier in pregnancy, possibly identify-
ing those at risk for (or protected from) post-term birth.
This could provide a basis for pharmacogenomic interven-
tions that shorten gestation tailored to the individual’s
genetic profile. Further research could also possibly lead
to prolonged gestation being treated as a long-term effect,
where both the acute and long-term consequences are
taken into account and mitigated in a low-risk (to both
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